Key statistics
As of last trade XBiotech Inc (4XB:STU) traded at 6.25, -31.32% below its 52-week high of 9.10, set on Apr 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.10 |
---|---|
High | 6.25 |
Low | 6.10 |
Bid | 5.90 |
Offer | 6.85 |
Previous close | 6.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 30.46m |
Free float | 19.76m |
P/E (TTM) | -- |
Market cap | 201.67m USD |
EPS (TTM) | -1.07 USD |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Announcements
- Les résultats de XBiotech d’une étude randomisée de phase 1/2 en double aveugle suggèrent l’émergence d’un traitement révolutionnaire potentiel contre le cancer du pancréas avancé
- Ergebnisse aus randomisierter, doppelt verblindeter Phase-I/II-Studie von XBiotech deuten auf mögliche bahnbrechende Behandlung gegen fortgeschrittenen Bauchspeicheldrüsenkrebs hin
- XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
- XBiotech entame la construction d’un nouveau centre de recherche et développement sur son campus de 19 hectares
- XBiotech beginnt mit dem Bau der neuen F&E-Anlage auf seinem 19 Hektar großen Campus
- XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
More ▼